2024
|
Invention
|
Il-15-based fusions to il-12 and il-18.
The invention features multi-specific fusion protein com... |
|
Invention
|
Senescence treatment with il-15-based fusions to il-7 and il-21.
The invention features multi-sp... |
|
Invention
|
Il-15-based molecules and methods of use thereof.
The invention features combination therapies u... |
|
Invention
|
Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complex.
The inventio... |
|
Invention
|
Compositions comprising il-15n72d-based molecules and bacillus calmette-guerin (bcg).
The invent... |
2023
|
Invention
|
Methods of treating a neoplasia with il-15-based molecules and ctla-4 antibody. The invention fea... |
|
Invention
|
Il-15-based fusions to il-12 and il-18. The invention features multi-specific fusion protein comp... |
|
Invention
|
Multimeric il-15 soluble fusion molecules and methods of making and using same.
The present inve... |
|
Invention
|
Il-15-based fusions to il-7 and il-21.
The invention features multi-specific fusion protein comp... |
|
Invention
|
Fusion molecules and il-15 variants. The instant invention provides soluble fusion protein comple... |
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of human diseases, animal diseases,... |
|
P/S
|
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, ... |
|
Invention
|
Il-15-based molecules and methods of treating a neoplasia. The invention features combination the... |
|
Invention
|
Method for treating neoplasia with an anti-cd38 antibody and an il-15:il-15r complex. The inventi... |
|
P/S
|
Medical research and product development; pharmaceutical research and development services; medic... |
|
P/S
|
Medical services; medical information; providing a website featuring medical information in the f... |
2022
|
Invention
|
Method of treating cancer with composition comprising il-15-based molecules and bcg. The inventio... |
|
Invention
|
Compositions comprising il-15-based molecules and immune checkpoint inhibitor antibodies. The inv... |
|
P/S
|
Pharmaceutical preparations and substances for the treatment of human diseases and animal disease... |
|
Invention
|
Il-15-based molecules and methods of use thereof. The invention features combination therapies us... |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer; |
2021
|
Invention
|
Il-15-based fusions to il-7 and il-21. The invention features multi-specific fusion protein compl... |
|
Invention
|
Multimeric il-15 soluble fusion molecules and methods of making and using same. The present inven... |
|
Invention
|
Multimeric il-15-based molecules. The invention features multi-specific protein complexes with on... |
2020
|
Invention
|
Il-15 fusion protein enhanced adoptive cell therapeutics. Combination therapies which include nat... |
|
Invention
|
Human immunodeficiency virus-specific t cell receptors.
Engineered TCR molecules specific to ret... |
|
Invention
|
Human immunodeficiency virus-specific t cell receptors. Engineered TCR molecules specific to retr... |
2019
|
Invention
|
Interleukin 15 (il-15) variants. The instant invention provides soluble fusion protein complexes ... |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer. |
|
Invention
|
Compositions comprising il-2 fusion proteins and methods for treating neoplasia.
The invention p... |
|
Invention
|
T cell receptor fusions and conjugates and methods of use thereof.
Featured is T cell receptor c... |
|
Invention
|
Superkine. Contemplated compositions and methods comprise chimeric molecule complexes that advant... |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer |
|
Invention
|
Anti-pdl1, il-15 and tgf-beta receptor combination molecules. The invention features multi-specif... |
|
Invention
|
Anti-pdl1, il-15 and tgf-beta receptor combination molecules. The invention features multi- speci... |
2018
|
Invention
|
Method of treating neoplasia with a multimeric il-15 soluble fusion molecule. The present inventi... |
2017
|
Invention
|
Hiv vpr-specific t-cell receptors. The instant invention provides TCRs having one or more amino a... |
|
Invention
|
Construction and characterization of multimeric il-15-based molecules with cd3 binding domains. T... |